Key Metrics
CiteScore 

12.5
H-Index 

179
Impact Factor 

10 - 15
Scite Index 

0.86 5-Year SI

SJR 

Q1Dermatology

SNIP 

3.66
Recommended pre-submission checks
Powered by 

Topics Covered on JAMA Dermatology
JAMA Dermatology Journal Specifications
| Overview | |
| Publisher | AMER MEDICAL ASSOC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1920 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in JAMA Dermatology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in JAMA Dermatology
Characterizing Longitudinal Melanonychia in Skin of Color.
- 20 May 2026
- JAMA dermatology
Skin Cancer Risk Profile of Asymptomatic Patients Seeking Periodic Skin Examinations for Skin Cancer Concerns.
- 20 May 2026
- JAMA dermatology
Isotretinoin Treatment in Adolescence and Adult Height.
- 20 May 2026
- JAMA dermatology
Parry-Romberg Syndrome With Concurrent en Coup de Sabre.
- 20 May 2026
- JAMA dermatology
Treatment of Actinic Keratosis via Destruction in Medicare Beneficiaries.
- 20 May 2026
- JAMA dermatology
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity
- 15 May 2026
- JAMA Dermatology
Characterizing Longitudinal Melanonychia in Skin of Color.
- 20 May 2026
- JAMA dermatology
Skin Cancer Risk Profile of Asymptomatic Patients Seeking Periodic Skin Examinations for Skin Cancer Concerns.
- 20 May 2026
- JAMA dermatology
Isotretinoin Treatment in Adolescence and Adult Height.
- 20 May 2026
- JAMA dermatology
Parry-Romberg Syndrome With Concurrent en Coup de Sabre.
- 20 May 2026
- JAMA dermatology
Treatment of Actinic Keratosis via Destruction in Medicare Beneficiaries.
- 20 May 2026
- JAMA dermatology
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity
- 15 May 2026
- JAMA Dermatology